News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,733 Results
Type
Article (5004)
Company Profile (17)
Press Release (219712)
Section
Business (82194)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3675)
Job Trends (3900)
News (120094)
Policy (7498)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14759)
ALS (19)
Alzheimer's disease (244)
Antibody-drug conjugate (ADC) (11)
Approvals (3690)
Artificial intelligence (39)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (46)
Cancer (424)
Cardiovascular disease (21)
Career advice (392)
Career pathing (2)
CAR-T (30)
Cell therapy (101)
Cervical cancer (2)
Clinical research (15998)
Collaboration (161)
Compensation (151)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (91)
Cystic fibrosis (16)
Data (490)
Depression (5)
Diabetes (38)
Diagnostics (2036)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40725)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37660)
Executive appointments (284)
FDA (3911)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (174)
Gene editing (15)
Generative AI (2)
Gene therapy (46)
GLP-1 (105)
Government (408)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (316)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7815)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2330)
Liver cancer (17)
Lung cancer (50)
Lymphoma (27)
Management (10)
Manufacturing (45)
MASH (27)
Medical device (3856)
Medtech (3857)
Mergers & acquisitions (7416)
Metabolic disorders (113)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (334)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (875)
Now hiring (2)
Obesity (50)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (23)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24519)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4769)
Phase II (6945)
Phase III (5537)
Pipeline (526)
Policy (5)
Postmarket research (625)
Preclinical (1864)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (64)
Real estate (1873)
Recruiting (8)
Regulatory (5100)
Reports (14)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (21)
Sickle cell disease (7)
Southern California (671)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
United States (6703)
Vaccines (34)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (18)
Last 7 days (213)
Last 30 days (843)
Last 365 days (10214)
2025 (2555)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11431)
Australia (1602)
California (1830)
Canada (667)
China (67)
Colorado (78)
Connecticut (90)
Delaware (28)
Europe (24433)
Florida (258)
Georgia (32)
Idaho (23)
Illinois (110)
India (6)
Indiana (60)
Iowa (1)
Japan (64)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (39)
Maryland (214)
Massachusetts (1477)
Michigan (84)
Minnesota (135)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (15)
New Jersey (537)
New Mexico (5)
New York (454)
North Carolina (316)
North Dakota (2)
Northern California (875)
Ohio (54)
Oklahoma (5)
Oregon (3)
Pennsylvania (332)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (671)
Tennessee (35)
Texas (215)
Utah (57)
Virginia (41)
Washington D.C. (8)
Washington State (161)
West Virginia (2)
Wisconsin (20)
224,733 Results for "astrotech corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Astrotech Appoints Jim Becker to Board of Directors
Astrotech Corporation (Nasdaq: ASTC) announced today that it has appointed Jim Becker to its Board of Directors.
June 23, 2022
·
4 min read
Business
Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.
May 12, 2022
·
9 min read
Business
Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022.
August 24, 2022
·
5 min read
Business
Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases
Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus.
June 23, 2022
·
5 min read
Deals
Astrotech Begins Search for Strategic Acquisitions
Astrotech Corporation now intends to actively pursue strategic and accretive acquisition opportunities.
November 17, 2021
·
4 min read
Business
Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results
Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.
February 11, 2022
·
10 min read
Lone Star Bio
Astrotech Engages Sanmina to Scale Manufacturing
Astrotech Corporation announced that its Astrotech Technologies, Inc. subsidiary has entered into an agreement with Sanmina Corporation to manufacture its mass spectrometry products.
March 30, 2021
·
2 min read
Business
Astrotech Reports Fiscal Year 2021 Financial Results
Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the fiscal year ended June 30, 2021.
September 20, 2021
·
8 min read
Business
Astrotech Reports First Quarter of Fiscal Year 2022 Financial Results
Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the first quarter of fiscal year 2022, which ended September 30, 2021.
November 12, 2021
·
8 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
1 of 22,474
Next
